• 1
    Fishman, J. A., Emery V., Freeman, R., Pascual, M., Rostaing, L., Schlitt, H. J., Sgarabotto, D. et al., Cytomegalovirus in transplantation – challenging the status quo. Clin. Transplant. 2007. 21: 149158.
  • 2
    Emery, V. C. Cytomegalovirus: recent progress in understanding pathogenesis and control. QJM 2012. 105: 401405.
  • 3
    Emery, V. C., Cope, A. V., Bowen, E. F., Gor D. and Griffiths P. D. The dynamics of human cytomegalovirus replication in vivo. J. Exp. Med. 1999. 190: 177182.
  • 4
    Sylwester, A. W., Mitchell, B. L., Edgar, J. B., Taormina, C., Pelte, C., Ruchti, F., Sleath, P. R. et al., Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J. Exp. Med. 2005. 202: 673685.
  • 5
    Noyola, D. E., Fortuny, C., Muntasell, A., Noguera-Julian, A., Muñoz-Almagro, C., Alarcón, A., Juncosa, T. et al., Influence of congenital human cytomegalovirus infection and the NKG2C genotype on NK-cell subset distribution in children. Eur. J. Immunol. 2012. 42: 32563266.
  • 6
    Lechner, F., Cuero, A. L., Kantzanou M. and Klenerman P. Studies of human antiviral CD8 +lymphocytes using class I peptide tetramers. Rev. Med. Virol. 2001. 11: 1122.
  • 7
    Britt, W. J. and Mach, M. Human cytomegalovirus glycoproteins. Intervirology 1996. 39: 401412.
  • 8
    Macagno, A., Bernasconi, N. L., Vanzetta, F., Dander, E., Sarasini, A., Revello, M. G., Gerna, G. et al. Isolation of human monoclonal antibodies that potently neutralize human cytomegalovirus infection by targeting different epitopes on the gH/gL/UL128–131A complex. J. Virol. 2010. 84: 10051013.
  • 9
    Fouts, A. E., Chan, P., Stephan, J. P., Vandlen, R. and Feierbach B. Antibodies against the gH/gL/UL128/UL130/UL131 complex comprise the majority of the anti-cytomegalovirus (anti-CMV) neutralizing antibody response in CMV hyperimmune globulin. J. Virol. 2012. 86: 74447447.
  • 10
    Raeiszadeh, M., Kopycinski, J., Paston, S. J., Diss, T., Lowdell, M., Hardy, G. A., Hislop, A. D. et al., The T cell response to persistent herpes virus infections in common variable immunodeficiency. Clin. Exp. Immunol. 2006. 146: 234242.
  • 11
    Marashi, S. M., Raeiszadeh, M., Enright, V., Tahami, F., Workman, S., Chee, R., Webster, A. D. et al., Influence of cytomegalovirus infection on immune cell phenotypes in patients with common variable immunodeficiency. J. Allergy Clin. Immunol. 2012. 129: 13491356.e3.
  • 12
    Marashi, S. M., Raeiszadeh, M., Workman, S., Rahbar, A., Soderberg-Naucler, C., Klenerman, P., Chee, R. et al., Inflammation in common variable immunodeficiency is associated with a distinct CD8(+) response to cytomegalovirus. J. Allergy Clin. Immunol. 2011. 127: 13851393.e4.
  • 13
    Zanghellini, F., Boppana, S. B., Emery, V. C., Griffiths, P. D. andPass R. F. Asymptomatic primary cytomegalovirus infection: virologic and immunologic features. J. Infect. Dis. 1999. 180: 702707.
  • 14
    Ritter, M., Schmidt, T., Dirks, J., Hennes, P., Juhasz-Böss, I., Solomayer, E. F., Gortner, L. et al., Cytomegalovirus-specific T cells are detectable in early childhood and allow assignment of the infection status in children with passive maternal antibodies. Eur. J. Immunol. 2013. 43: 10991108.
  • 15
    Sester, M., Gärtner, B. C., Sester, U., Girndt, M., Mueller-Lantzsch N. and Köhler H. Is the cytomegalovirus serologic status always accurate? A comparative analysis of humoral and cellular immunity. Transplantation 2003. 76: 12291230.
  • 16
    Thakur, A., Pedersen, L. E. and Jungersen G. Immune markers and correlates of protection for vaccine induced immune responses. Vaccine 2012. 30: 49074920.